Balance Sheet Dive: Incyte Corp. (INCY)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $58.57 in the prior trading day, Incyte Corp. (NASDAQ: INCY) closed at $59.03, up 0.79%. In other words, the price has increased by $0.79 from its previous closing price. On the day, 5.68 million shares were traded. INCY stock price reached its highest trading level at $59.1 during the session, while it also had its lowest trading level at $57.95.

Ratios:

Our goal is to gain a better understanding of INCY by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.78. For the most recent quarter (mrq), Quick Ratio is recorded 3.43 and its Current Ratio is at 3.47. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on May 23, 2024, initiated with a Hold rating and assigned the stock a target price of $55.

On February 23, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $81.Jefferies initiated its Buy rating on February 23, 2024, with a $81 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 03 ’24 when Stein Steven H sold 7,365 shares for $65.51 per share. The transaction valued at 482,481 led to the insider holds 90,218 shares of the business.

Iyengar Vijay K sold 657 shares of INCY for $42,705 on Jan 02 ’24. The EVP, GMAPPS now owns 43,412 shares after completing the transaction at $65.00 per share. On Dec 13 ’23, another insider, Tray Thomas, who serves as the Principal Accounting Officer of the company, sold 1,067 shares for $62.37 each. As a result, the insider received 66,549 and left with 23,436 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INCY now has a Market Capitalization of 13273190400 and an Enterprise Value of 9441347584. As of this moment, Incyte’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.92, and their Forward P/E ratio for the next fiscal year is 11.68. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.80. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.52 while its Price-to-Book (P/B) ratio in mrq is 2.46. Its current Enterprise Value per Revenue stands at 2.506 whereas that against EBITDA is 11.776.

Stock Price History:

Over the past 52 weeks, INCY has reached a high of $67.36, while it has fallen to a 52-week low of $50.27. The 50-Day Moving Average of the stock is 7.10%, while the 200-Day Moving Average is calculated to be 1.55%.

Shares Statistics:

The stock has traded on average 2.32M shares per day over the past 3-months and 4236880 shares per day over the last 10 days, according to various share statistics. A total of 224.29M shares are outstanding, with a floating share count of 220.99M. Insiders hold about 1.72% of the company’s shares, while institutions hold 98.18% stake in the company. Shares short for INCY as of 1715731200 were 7540811 with a Short Ratio of 3.25, compared to 1713139200 on 8265710. Therefore, it implies a Short% of Shares Outstanding of 7540811 and a Short% of Float of 5.37.

Earnings Estimates

The current rating of Incyte Corp. (INCY) is the result of assessments by 13.0 analysts actively engaged in evaluating its market dynamics.On average, analysts expect EPS of $1.09 for the current quarter, with a high estimate of $1.26 and a low estimate of $0.82, while EPS last year was $0.99. The consensus estimate for the next quarter is $1.19, with high estimates of $1.41 and low estimates of $0.93.

Analysts are recommending an EPS of between $4.81 and $3.83 for the fiscal current year, implying an average EPS of $4.3. EPS for the following year is $5.35, with 16.0 analysts recommending between $6.93 and $4.45.

Revenue Estimates

17 analysts predict $1.01B in revenue for the current quarter. It ranges from a high estimate of $1.06B to a low estimate of $938.2M. As of the current estimate, Incyte Corp.’s year-ago sales were $954.61MFor the next quarter, 17 analysts are estimating revenue of $1.05B. There is a high estimate of $1.08B for the next quarter, whereas the lowest estimate is $1B.

A total of 20 analysts have provided revenue estimates for INCY’s current fiscal year. The highest revenue estimate was $4.25B, while the lowest revenue estimate was $3.87B, resulting in an average revenue estimate of $4.09B. In the same quarter a year ago, actual revenue was $3.7BBased on 20 analysts’ estimates, the company’s revenue will be $4.53B in the next fiscal year. The high estimate is $4.78B and the low estimate is $4.18B.

Most Popular